The vanguard and the people it serves
The overarching aim of the cancer vanguard is to ensure everyone receives high quality cancer care when and where they need it.
It is a partnership led by three organisations:
- The Christie NHS Foundation Trust
- The Royal Marsden NHS Foundation Trust
- University College London Hospitals NHS Foundation Trust
It was established to pilot new models of cancer care across London and Manchester to improve the rates of earlier diagnosis and detection, improve patient outcomes and experience and reduce variation.
The vanguard serves a population of over 10 million people, providing it with an unprecedented opportunity to transform and create new models of cancer care that can be reproduced nationally.
It will deliver a coordinated, whole system approach to cancer care, looking at prevention and education as well as early diagnosis and treatment. It will work to improve the care of those living with and beyond cancer, as well as palliative and end of life care.
Hospitals, GPs and commissioners have all had input into how the cancer vanguard operates, and will continue to do so. More importantly, throughout the process patients, their families and carers have been at the heart of the design of the vanguard and will be meaningfully involved at every state in shaping this new system of cancer care.
What is changing?
This vanguard was established to help deliver high quality, patient centred and financially sustainable cancer care. It will also work to deliver certain recommendations in the national cancer strategy Achieving World-Class Cancer Outcomes – A Strategy for England 2015-2020.
Each of the vanguard partners leads a local delivery system – Greater Manchester Cancer Vanguard Innovation, Royal Marsden (RM) Partners in north west and south west London, and University College London Hospitals (UCLH) Cancer Collaborative covering north central and north east London and west Essex, – which comprises health organisations in their area, including clinical commissioning groups, NHS acute trusts, community services and hospices.
By working radically yet inclusively across the defined population, the Cancer Vanguard will provide innovative, high quality evidence based care across the whole patient pathway.
- Shifting emphasis towards prevention and earlier diagnosis has the potential to dramatically improve patient outcomes
- Working together across a network will ensure that resources are used more efficiently and enable clinicians to provide patients with the best cancer care available
Contact Accountable Cancer Network
- Website: Greater Manchester Cancer Vanguard Innovation
- Website: RM Partners
- Website: UCLH Cancer Collaborative